hARnessing CAbozantinib and Durvalumab Immuno-oncology Association: ARCADIA Study"

  • STATUS
    Recruiting
  • days left to enroll
    58
  • participants needed
    122
  • sponsor
    Fondazione IRCCS Istituto Nazionale dei Tumori, Milano
Updated on 4 March 2021

Summary

Cabozantinib plus Durvalumab in patients with advanced and chemotherapy-treated bladder carcinoma, of urothelial and non-urothelial histology: an open-label, single-centre, phase 2, single-arm proof-of-concept trial: ARCADIA study

Description

an open-label, single-centre, phase 2,

Details
Condition bladder cancer, bladder cancer, Bladder Carcinoma, Urothelial Cancer, Urothelial Cancer, Bladder Carcinoma, carcinoma of the bladder
Treatment durvalumab, Cabozantinib
Clinical Study IdentifierNCT03824691
SponsorFondazione IRCCS Istituto Nazionale dei Tumori, Milano
Last Modified on4 March 2021

Eligibility

How to participate?

Step 1 Connect with a study center
What happens next?
  • You can expect the study team to contact you via email or phone in the next few days.
  • Sign up as volunteer  to help accelerate the development of new treatments and to get notified about similar trials.

You are contacting

Investigator Avatar

Primary Contact

site

Additional screening procedures may be conducted by the study team before you can be confirmed eligible to participate.

Learn more

If you are confirmed eligible after full screening, you will be required to understand and sign the informed consent if you decide to enroll in the study. Once enrolled you may be asked to make scheduled visits over a period of time.

Learn more

Complete your scheduled study participation activities and then you are done. You may receive summary of study results if provided by the sponsor.

Learn more

Similar trials to consider

Loading...

Not finding what you're looking for?

Every year hundreds of thousands of volunteers step forward to participate in research. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.

Sign up as volunteer

user name

Added by • 

 • 

Private

Reply by • Private
Loading...

Lorem ipsum dolor sit amet consectetur, adipisicing elit. Ipsa vel nobis alias. Quae eveniet velit voluptate quo doloribus maxime et dicta in sequi, corporis quod. Ea, dolor eius? Dolore, vel!

  The passcode will expire in None.
Loading...

No annotations made yet

Add a private note
  • abc Select a piece of text from the left.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.
Add a private note